Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) And Control Measures to Prevent The Spread of Infections in Patients across Trat Hospital
Keywords:
Carbapenem-Resistant Enterobacteriaceae (CRE), Antimicrobial susceptibility, PrevalenceAbstract
At present, the increasing prevalence of Carbapenem-resistant Enterobacteriaceae (CRE) has become a serious problem in many countries around the world including Thailand. The objectives of this study is to investigate the prevalence of Carbapenem-resistant Enterobacteriaceae (CRE) isolated from patients in Trat Hospital during 1st January 2014 to 31st December 2018. A total of 5,311 isolates of Enterobacteriaceae were determined the antimicrobial susceptibility by Kirby-Bauer disc diffusion using Carbapenems (Imipenem or Meropenem). The frequency of CRE in 2014 to 2018 were constantly increasing with 0.11 %, 1.27 %, 2.50 % and 3.45 %, respectively. Interestingly, the frequency of Carbapenem-resistant Escherichia coli was dramatically increased from 1.99 % in 2016 to 4.82 % in 2017. The small epidemic of Carbapenem-resistant E. coli was found in MED and ICU which these isolates had the same antimicrobial resistance pattern. Accordingly, the spread of CRE might be caused by a medical facility, medical staff or medical equipment. Later, Trat hospital has reviewed the control measures and improved the understanding of the guidelines to prevent and control the spread of CRE in the hospital includingisolation of patients, separation of equipments, strictly contact precautions, campaign for rational drug use and CRE notification system of laboratory. These actions could lead to the decreasing in the frequency of CRE in Trat hospital to be 2.30 % of isolates in 2018. This study provided useful information to consider an appropriate antimicrobial treatment in infectious diseases and to improve the effective control measures to prevent the spread of antimicrobial resistance in the hospital.
References
Arsheewa, Weewan. (2016). Prevalence of Carbapenemase Enzyme in Clinical Isolates ofCarbapenem-Resistant Enterobacteriaceae from Prapokklao
Hospital in 2012 – 2013. The Journal of Prapokklao Hospital Clinical Medical Education Center. 33(4): 314-325. (in Thai).
Castanheira M, Mendes RE, Woosley LN, Jones RN. (2011). Trends in Carbapenemase-Producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007–09). J Antimicrob Chemother. 66(6): 1409–1411.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R. (2010). Emergence of a New Antibiotic Resistance Mechanism in India, Pakistan, and the UK: a Molecular, Biological, and Epidemiological Study. Lancet Infect Dis. 10(9): 597–602.
Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S. (2016). Epidemiology and Burden of Multidrug-Resistant Bacterial Infection in a Developing Country. Elife. 5:e18082.
Livermore DM. (2012). Current Epidemiology and Growing Resistance of Gram-Negative Pathogens. Korean J Intern Med. 27(2): 128.
NARST: National Antimicrobial Resistance Surveillance Center, Thailand. Retrieved March 29, 2019, from http://narst.dmsc. moph.go.th/data/map2561. Pdf (in Thai).
Netikul, Thidarat and Kiratisin, Pattarachai. (2015). Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumoniae ST340 at a University Hospital in Thailand. PloS One. 10(9): e0139116. (inThai).
O’Neill J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations: The Review on Antimicrobial Resistance Chaired By Jim O’Neill. Wellcome Trust HM Gov Lond.
Rimrang, Benchamas and Teamwork. (2012). Emergence of NDM-1- and IMP-14aproducing Enterobacteriaceae in Thailand. Journal of Antimicrobial Chemotherapy.67(11): 2626–2630. (in Thai).
Thongkoom, Prakaithip and Teamwork. (2017). Carbapenem-Resistant Enterobacteriaceae at Rajavithi Hospital: Results of a Microbiology Laboratory Program (2009-2015). Journal of Medical Association of Thailand. 100(1): 212-220. (in Thai).
Unahalekhaka, Akeau. (2013). Epidemiology and Evidence-Based Practice Guideline in Prevention of Hospital-Associated Infection. Chiang Mai: Mingmuangnavarat Company LTD. (in Thai).
Wongprasit, Pawinee and Teamwork. (2012). Epidemiology and Clinical Review of Carbapenem- Resistant Enterobacteriaceae New Delhi Metallo Betalactamase (NDM-1) in Burirum. Khon Kaen Medical Journal. 36(3): 46–51. (in Thai).
Xia Y, Liang Z, Su X, Xiong Y. (2012). Characterization of Carbapenemase Genes in Enterobacteriaceae Species Exhibiting Decreased Susceptibility to Carbapenems in a University Hospital in Chongqing, China. Ann Lab Med. 32(4): 270–275.
Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K. (2009). Characterization of a New Metallo-Beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumonia Sequence Type 14 from India. Antimicrob Agents Chemother. 53(12): 5046–5054.
Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B. (2018). Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 62(2).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Journal of Department of Health Service Support-วารสารวิชาการกรมสนับสนุนบริการสุขภาพ
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.